Godavari Drugs Statistics

Total Valuation

Godavari Drugs has a market cap or net worth of INR 951.86 million. The enterprise value is 1.67 billion.

Market Cap	951.86M
Enterprise Value	1.67B

Important Dates

The next confirmed earnings date is Saturday, May 30, 2026.

Earnings Date	May 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Godavari Drugs has 7.53 million shares outstanding. The number of shares has decreased by -0.06% in one year.

Current Share Class	7.53M
Shares Outstanding	7.53M
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	-0.31%
Owned by Insiders (%)	59.86%
Owned by Institutions (%)	n/a
Float	2.72M

Valuation Ratios

The trailing PE ratio is 25.75.

PE Ratio	25.75
Forward PE	n/a
PS Ratio	0.96
PB Ratio	2.10
P/TBV Ratio	2.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	45.19
EV / Sales	1.69
EV / EBITDA	14.77
EV / EBIT	18.85
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	1.63
Debt / EBITDA	6.54
Debt / FCF	n/a
Interest Coverage	2.14

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	5.71%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	4.33%
Revenue Per Employee	9.31M
Profits Per Employee	348,255
Employee Count	106
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Godavari Drugs has paid 11.94 million in taxes.

Income Tax	11.94M
Effective Tax Rate	24.44%

Stock Price Statistics

The stock price has increased by +25.05% in the last 52 weeks. The beta is 0.03, so Godavari Drugs's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	+25.05%
50-Day Moving Average	92.60
200-Day Moving Average	86.00
Relative Strength Index (RSI)	70.71
Average Volume (20 Days)	18,832

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Godavari Drugs had revenue of INR 986.94 million and earned 36.92 million in profits. Earnings per share was 4.91.

Revenue	986.94M
Gross Profit	277.63M
Operating Income	88.50M
Pretax Income	48.85M
Net Income	36.92M
EBITDA	112.98M
EBIT	88.50M
Earnings Per Share (EPS)	4.91

Full Income Statement

Balance Sheet

The company has 22.93 million in cash and 739.28 million in debt, giving a net cash position of -716.35 million or -95.13 per share.

Cash & Cash Equivalents	22.93M
Total Debt	739.28M
Net Cash	-716.35M
Net Cash Per Share	-95.13
Equity (Book Value)	453.87M
Book Value Per Share	60.32
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	24.48M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 28.13%, with operating and profit margins of 8.97% and 3.74%.

Gross Margin	28.13%
Operating Margin	8.97%
Pretax Margin	4.95%
Profit Margin	3.74%
EBITDA Margin	11.45%
EBIT Margin	8.97%
FCF Margin	n/a

Dividends & Yields

Godavari Drugs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.06%
Shareholder Yield	0.06%
Earnings Yield	3.88%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2